- Advertisement -

Driving behavior less ‘robotic’ thanks to new Delft model

Credit: TU Delft Researchers from TU Delft have now developed a new model that describes driving behaviour...

Stem cell study reveals how neurons from PTSD patients react to stress

Stem cell-derived neurons from combat veterans with post-traumatic stress disorder (PTSD) react differently to a stress hormone than those from veterans without PTSD, a...

Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab

Biogen CEO Michel Vounatsos Biogen saw its shares surge nearly 40% in morning trading today after surprising analysts by announcing that it plans to file...

Phlow

Candidates: Various generic therapeutics against COVID-19 Types: Not specified Status: Phlow, a public benefit drug manufacturing corporation, announced May 19 that it received a commitment of...

Scientific prowess in biotechnology to help fight challenges of hunger,poverty; Ch...

ISLAMABAD, Apr 16 (APP): Federal Minister for Science and Technology (Now Information and Broadcasting Minster) Chaudhry Fawad Hussain Friday said that scientific prowess in...

PET offers more precise screening method to select candidates for radionuclide...

New subset of neuroendocrine tumor patients may benefit from therapy Credit: TA Hope, University of California-San Francisco, and C Millo, National Cancer Institute

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

Register Now Emily Gaither Engineer III, Downstream PurificationThermo Fisher Scientific View Bio ...

StockWatch: Novartis Loses More than Market Value After Phase III Failure

Novartis (SIX Swiss: NOVN and NYSE: NVS) lost more than just the roughly $30 billion in market capitalization (share price times the number of...

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

Register Now Emily Gaither Engineer III, Downstream PurificationThermo Fisher Scientific View Bio ...

StockWatch: Novartis Loses More than Market Value After Phase III Failure

Novartis (SIX Swiss: NOVN and NYSE: NVS) lost more than just the roughly $30 billion in market capitalization (share price times the number of...

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more...

more new items

Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies

Register Now Emily Gaither Engineer III, Downstream PurificationThermo Fisher Scientific View Bio ...

StockWatch: Novartis Loses More than Market Value After Phase III Failure

Novartis (SIX Swiss: NOVN and NYSE: NVS) lost more than just the roughly $30 billion in market capitalization (share price times the number of...

Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Manus, The BioAlternatives Company®, and the University of Texas at Austin say they have completed a BioMADE-sponsored program to make industrial yeast fermentation more...